Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

SARS-CoV-2 has caused a global health crisis and mass vaccination programmes provide
the best opportunity for controlling transmission and protecting populations. Despite the …

Gastric antral vascular ectasia (GAVE), though a rare disorder, causes up to 4% of non-
variceal upper GI bleeding. This paper gives an overview of studies examining clinical …

Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …

Background & Aims Anti–tumor necrosis factor (anti-TNF) therapies are the most widely
used biologic drugs for treating immune-mediated diseases, but repeated administration can …

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems
globally. Early insights have been made possible by rapid sharing of data from China and …

2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

Background: Enabling women with inflammatory bowel diseases (IBD) to have successful
pregnancies requires complex decisions. The study aimed to assess patients' views on IBD …

Objective Antitumour necrosis factor (anti-TNF) drugs impair protective immunity following
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …

Background Risankizumab, an anti-interleukin 23 antibody, was superior to placebo in
achieving clinical and endoscopic remission at week 12 in a randomised, phase 2 induction …